Polymorphisms in the MAPT gene are also involved in the pathologies of Alzheimer's disease (AD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) (Vandrovcova et al., 2009). This evidence concerns the gene MAPT and Alzheimer disease.